Small ETFs: Boasts Lower Fees with VB vs ISCB’s Higher Dividend Yield
Two popular small-cap ETFs, VB and ISCB, offer different advantages. VB shines on costs and liquidity, while ISCB may...
Articles — Page 1074
Real Estate Rebound? Play: A 3X Smart Investor Strategy
Cracking the code on a potential real estate rebound? play means stacking three strategic bets: affordable debt, grow...
Intel Stock Gotten Ahead: Can Lip-Bu Tan Turnaround Pay Off
Intel stock has moved faster than its turnaround plan in many eyes. As Lip-Bu Tan reshapes the company, investors mus...
Year: Fund Million Trimas — Why a Trim Made Sense Now
A mid-size fund reduced its TriMas stake by about $5 million after a strong run, but didn’t exit the position entirel...
Chemed Stock Down Year: Key Trends and Investment Tips
Chemed has faced a challenging year, even as its business lines stay essential. This article breaks down the drivers ...
Bitcoin Price Move Horizon Signals Big Breakout Risk
Traders eye a pivotal moment as bitcoin price move horizon narrows, with BTC hovering near critical support around $6...
OpenClaw Creator Peter Steinberger: AI Innovator Rising
After a long hiatus from the tech scene, Peter Steinberger—a millennial coder turned OpenClaw founder—re-emerged to w...
Elon Musk Pushing Space Data Centers, Facing Skepticism
Elon Musk is pursuing a bold plan to run AI data centers in space, backed by SpaceX filings and xAI ambitions. But in...
Icon Amsterdam Reports Record 2025, Plans U.S. Expansion
Icon Amsterdam says 2025 was its best year yet after a broad restructuring, and it plans a phased U.S. entry in 2026,...
Bitcoin Range-Bound Under Pressure Near $55K Focus
Bitcoin remains range-bound under pressure around the $55,000 mark as on-chain metrics flag weak demand. Analysts say...
Activist Starboard Says Riot AI Pivot Worth Up to $21B
Starboard Value is pressing Riot Platforms to accelerate its pivot into AI data centers, arguing Texas power assets c...
Immunova to Acquire AlphaTON Subsidiary Iox Therapeutics
Immunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...